For the rapid testing and swift diagnosis of Chlamydia trachomatis infection, Inverness Medical offers the Clearview Chlamydia MF test. It is estimated that there are 92 million Chlamydia infections a year, making it the most common sexually transmitted disease worldwide.
Although treatable, the challenge in diagnosing Chlamydia is often the lack of symptoms. With as many as a quarter of patients never returning for their results and treatment, Clearview Chlamydia MF ensures diagnosis and treatment can be made in a single patient visit, reducing patient anxiety and the spread of infection.
Giving rapid results in as little as 30 minutes, Clearview Chlamydia MF is suitable for both men and women by detecting Chlamydia trachomatis antigen using either female endocervical swabs or male urine samples. The easy-to-use lateral flow test has in-built procedural controls which reliably confirm the test has worked correctly.
The test uses a unique heating step in the testing process which gives Clearview Chlamydia MF its high sensitivity, meaning clinicians can be confident in the test results.
Early treatment of Chlamydia is essential in preventing the development of future complications. In women, if left untreated Chlamydia can cause infertility and an increased risk of ectopic pregnancies.
In men the infection can cause arthritis, as well as damage to sperm. With Clearview Chlamydia MF, Inverness Medical offers a practical answer to improving patient care and reducing the rise in this easily
treatable infection.
Product directory
